Clinical Trials Browser

Phase 1/2 × Carcinoma, Renal Cell × Introns × Clear all

NCT00522249 2016-03-17

Study of Pegylated Alfa Interferon, Sunitinib and Tarceva in Patients With Metastatic RCC

Phase 1/2 Terminated

Carcinoma, Renal Cell